BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 14, 2001
View Archived Issues
A novel tumor suppressor gene activated by Ras available for licensing from NIH
Read More
Preliminary U.S. testing of Alprox-TD in severe ED patients completed
Read More
Avax makes notable progress in AC vaccine development program during 2000
Read More
Phase III trial of IntraBiotics' oral ramoplanin experiences delay
Read More
Boston Life Sciences reports successful phase II outcome with Altropane for ADHD diagnosis
Read More
Millennium and Abbott form alliance in metabolic disease
Read More
Chiron BLA for HIV-1 and HCV diagnostic accepted by FDA
Read More
Human factor Xa inhibitor JTV-803 is a promising orally active antithrombotic agent
Read More
Novel nonpeptide compound Y-40018 displays high selectivity for human chymase
Read More
Potential new treatment for dermatitis evaluated in animal models of contact hypersensitivity
Read More
Aromatase inhibitor effective in infertile women with unsatisfactory response to clomiphene
Read More
TranXenoGen licenses novel anticancer protein
Read More
High-dose, long-term atorvastatin therapy may reduce atherosclerosis progression
Read More
Patient enrollment complete in AstraZeneca's CHARM program for heart failure
Read More
Second-generation Vitaxin enters phase I evaluation for treatment of solid tumors
Read More
Clinical trial results support once-daily desloratadine as safe, effective antiallergic medication
Read More
MedImmune's UTI vaccine enters second phase II trial
Read More
Hollis-Eden files IND for clinical evaluation of HE-2200
Read More
ETA antagonist TBC-3214 emerges from structure-bioavailability studies as clinical candidate
Read More
Neuroprotective series claimed by Vernalis
Read More
Ceramide analogues from Bracco induce apoptosis in cancer cells
Read More
Almirall Prodesfarma presents new phosphodiesterase inhibitors
Read More
Schering prepares vitamin D derivatives with improved side effect and metabolic profile
Read More
Antiprotozoal apicidin derivatives that act by inhibiting histone deacetylase
Read More
High-affinity, selective 5-ht6 receptor ligands emerge from research at Merck
Read More
Japanese patent issued to Kissei for inhibitors of cathepsin and papain
Read More
Metabotropic glutamate receptor antagonists and their use
Read More
Antiviral agents discovered at Bayer particularly useful against cytomegalovirus
Read More